Jad Chahoud

Jad Chahoud

Hematology | Oncology
12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Journal: JCO oncology practice
Published: July 06, 2026

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

Journal: The New England journal of medicine
Published: July 01, 2026

Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges.

Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges.

Journal: Vaccines
Published: May 27, 2026

Multidisciplinary Care of Patients With Penile Cancer.

Multidisciplinary Care of Patients With Penile Cancer.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: March 17, 2026

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

Journal: Nature communications
Published: February 02, 2026

Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors.

Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors.

Journal: Urologic oncology
Published: November 04, 2025

Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma.

Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma.

Journal: Future oncology (London, England)
Published: October 30, 2025

Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 27, 2025

Geospatial and Cell Density Analysis Using Multiplex Immunofluorescence Reveals an Important Role of Clustering Patterns of Immunosuppressive Macrophages in Survival Outcomes of Penile Squamous Cell Carcinoma.

Geospatial and Cell Density Analysis Using Multiplex Immunofluorescence Reveals an Important Role of Clustering Patterns of Immunosuppressive Macrophages in Survival Outcomes of Penile Squamous Cell Carcinoma.

Journal: Cancers
Published: October 23, 2025

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025

Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape.

Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape.

Journal: Journal for immunotherapy of cancer
Published: August 24, 2025
Showing 1-12 of 116

Last Updated: 09/26/2026